Oncotelic Therapeutics's total assets for Q3 2024 were $26.78M, a decrease of -10.53% from the previous quarter. OTLC total liabilities were $18.65M for the fiscal quarter, a 1.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.